<DOC>
	<DOCNO>NCT00895544</DOCNO>
	<brief_summary>The main objective study ass immune response non-adjuvanted H5N1 influenza vaccine adult population administer accord single prime-boost schedule .</brief_summary>
	<brief_title>Immunogenicity Safety Study Single Prime-Boost Vaccination Schedule With H5N1 Influenza Vaccine Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female subject eligible participation study : 18 59 year age , inclusive , day screen understand study procedure , agree provision , give write informed consent prior study entry generally healthy , determine investigator 's clinical judgment collection medical history performance physical examination physically mentally capable participate study follow procedure agree keep daily record symptom duration study female childbearing potential : negative urine pregnancy test result within 24 hour prior schedule first vaccination agree employ adequate birth control measure duration study Subjects exclude participation study : history exposure H5N1 virus history vaccination H5N1 influenza vaccine high risk contract H5N1 influenza infection ( e.g . poultry worker ) currently history significant neurological , cardiovascular , pulmonary ( include asthma ) , hepatic , metabolic , rheumatic , autoimmune , hematological renal disorder inherit acquire immunodeficiency disease currently undergoing form treatment undergoing form treatment within 30 day prior study entry expect influence immune response . Such treatment include , limited , systemic high dose inhale ( &gt; 800Âµg/day beclomethasone dipropionate equivalent ) corticosteroid , radiation treatment immunosuppressive cytotoxic drug history severe allergic reaction anaphylaxis rash , dermatological condition tattoo may interfere injection site reaction rating receive blood product immunoglobulins within 90 day prior study entry donate blood plasma within 30 day prior study entry receive live vaccine within 4 week inactivate vaccine within 2 week prior vaccination study functional surgical asplenia know suspect problem alcohol drug abuse administer investigational drug within 6 week prior study entry concurrently participate clinical study include administration investigational product member team conduct study dependent relationship one study team member . Dependent relationship include close relative ( i.e. , child , partner/spouse , sibling , parent ) well employee investigator site personnel conduct study female : pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>